Anika Therapeutics Inc (NASDAQ:ANIK)

33.07
Delayed Data
As of May 28
 +0.22 / +0.67%
Today’s Change
31.36
Today|||52-Week Range
51.40
-18.83%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 50.75, with a high estimate of 56.00 and a low estimate of 45.50. The median estimate represents a +53.46% increase from the last price of 33.07.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.40
Sales
$23.0M
Reporting Date
Jul 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 71.74%
 
 
 
 
 
 
Growthannually -48.01%
 
 
 
 
 
 

Sales

Growthquarterly 47.90%
 
 
 
 
 
 
Growthannually -20.98%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account